Offer - Urjas Oil for just ₹ 1 X
Platipar, a prescription drug, is manufactured in various forms such as Injection, Infusion. It is typically used for the treatment of Ovarian Cancer, Testicular Cancer, Bladder Cancer. Other than this, Platipar has some other therapeutic uses, which have been discussed ahead.
The right dosage of Platipar depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
The most common side effects of Platipar are Joint pain, Swelling. Some other side effects of Platipar have been listed ahead. Such side effects of Platipar normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Platipar's effect during pregnancy is Severe and Severe while nursing. In addition, Platipar's effects on the liver, heart and kidney are discussed below in the Platipar related warnings section.
Platipar is not recommended if you suffer from certain medical conditions as it can have adverse effects. Kidney Disease are examples of such conditions. Some other conditions that can be affected by Platipar are listed in the contraindications section below.
Drug interactions for Platipar have been reported in the medical literature. Refer to the list below for further details.
You should also be aware that Platipar is not safe while driving, and is not addiction.
Platipar is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Adult(Female) |
|
Adult(Male) |
|
Is the use of Platipar safe for pregnant women?
Pregnant women may get severe side effects after taking Platipar. If you are pregnant, do not take Platipar without a doctor's advice.
Is the use of Platipar safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Platipar. It should only be taken after medical advice.
What is the effect of Platipar on the Kidneys?
There may be some adverse effects on kidney after taking Platipar. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Platipar on the Liver?
Platipar is not harmful for the liver.
What is the effect of Platipar on the Heart?
Platipar is completely safe for the heart.
Platipar should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Platipar unless your doctor advises you to do so -
Is this Platipar habit forming or addictive?
Forming a habit of Platipar has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Platipar can make you feel drowsy.
Is it safe?
Platipar should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Platipar for mental disorders.
Interaction between Food and Platipar
Taking Platipar with food does not harm your health.
Interaction between Alcohol and Platipar
Information about the interaction of Platipar and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cisplatin
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 861
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 321-324